Clinical Trials Logo
  1. Home
  2. Peripheral Arterial Disease
  3. NCT01930071
  4. Details
NCT01930071 Clinical Trial

PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass

Peripheral Arterial Disease Clinical Trial

— PQB4FP1  

Official title:
PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01930071
Other study ID # STP 114
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2013
Est. completion date June 2015

Study information
Verified date February 2024
Source Endologix
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the safety of performing a percutaneous fem-pop bypass using the PQ Bypass Guidewire Delivery System and commercially available stent grafts.

Description:

Multi-center, single-arm first-in-man study utilizing the PQ Bypass Guide Wire Delivery System to access, deliver guidewires and implant stent grafts for a percutaneous femoropopliteal (fem-pop) bypass.

Recruitment information / eligibility
Status Completed
Enrollment 4
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Willing and able to provide informed consent - Age 18 or older - Rutherford Classification of 3-5 - Lesions =10cm in length considered to be: - Chronic total occlusion (100% stenosis) - Diffuse stenosis (>50% stenosis) with moderate to heavy calcification - In-stent restenosis (>50% stenosis) - Proximal and distal target vessels are 4.8 - 7.5 mm in diameter - Orifice and proximal 1cm of SFA is patent - Patent popliteal artery 3cm proximal to tibial plateau - At least 1 patent tibial artery to the foot - Patent femoral vein Exclusion Criteria: - History of deep vein thrombosis - Has a known sensitivity or allergy to contrast materials that cannot be adequately pre-treated - Has a known sensitivity or allergy to aspirin, heparin or anti-platelet medications - Documented in-sensitivity to anti-platelet medication - Has a known or previous coagulopathy - Pregnant or lactating - Untreated flow-limiting aortoiliac occlusive disease - Has renal failure (GFR < 30mL/min) - Major distal amputation (above the transmetatarsal) in the study or non-study limb - Patient has had a procedure on the target limb within 30 days - Previous bypass surgery on the target limb - Bypass length required is greater than 35cm

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• PQ Bypass Guide Wire Delivery System
The PQ Bypass Guide Wire Delivery System is used to bypass lesions in the peripheral vasculature percutaneously. A guidewire is placed from the artery proximal to the lesion to the artery distal to the lesion using the vein as a conduit with the Guidewire Delivery System. Once in place, commercially available stent grafts will be placed to complete the bypass.

Locations
Country Name City State
New Zealand Auckland City Hospital Auckland

Sponsors (1)
Lead Sponsor Collaborator
Endologix

Country where clinical trial is conducted

New Zealand, 

Outcome
Type Measure Description Time frame Safety issue
Primary Primary Patency 30 days
See also
  Status Clinical Trial Phase
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Active, not recruiting NCT03987061 - MOTIV Bioresorbable Scaffold in BTK Artery Disease N/A
Recruiting NCT03506633 - Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients N/A
Active, not recruiting NCT03506646 - Dietary Nitrate Supplementation and Thermoregulation N/A
Active, not recruiting NCT04677725 - NEtwork to Control ATherothrombosis (NEAT Registry)
Recruiting NCT05961943 - RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients N/A
Recruiting NCT06047002 - Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease
Completed NCT03185052 - Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach N/A
Recruiting NCT05992896 - A Study of Loco-Regional Liposomal Bupivacaine Injection Phase 4
Completed NCT04635501 - AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial N/A
Recruiting NCT04584632 - The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery N/A
Withdrawn NCT03994185 - The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease N/A
Withdrawn NCT03538392 - Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Recruiting NCT02915796 - Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty Phase 1
Active, not recruiting NCT02900924 - Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
Completed NCT02901847 - To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities. N/A
Not yet recruiting NCT02387450 - Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication Phase 2/Phase 3
Not yet recruiting NCT02455726 - Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease N/A
Withdrawn NCT02126540 - Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries N/A
Completed NCT02022423 - Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease N/A